Longitudinal antibody responses to peanut following probiotic and peanut oral immunotherapy in children with peanut allergy-Reference-Cited by-同舟云学术

Longitudinal antibody responses to peanut following probiotic and peanut oral immunotherapy in children with peanut allergy

Published:2022-04-29 Issue:6 Volume:52 Page:735-746
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Experimental Allergy

Author:

Hsiao Kuang‐Chih¹²³^ORCID,Ponsonby Anne‐Louise⁴⁵^ORCID,Ashley Sarah³^ORCID,Lee Cassandra Yuen Yan³⁶,Jindal Lalita³⁷,Tang Mimi L. K.³⁸⁹^ORCID,Loke Paxton,Axelrad Christine,Pitkin Sigrid,Robinson Marnie,Tey Dean,Su Ee Lyn,

Affiliation:

1. Department of Immunology Starship Children's Hospital Auckland New Zealand

2. Department of Paediatrics University of Auckland Auckland New Zealand

3. Allergy Immunology Research Murdoch Childrens Research Institute Melbourne Victoria Australia

4. The Florey Institute of Neuroscience and Mental Health University of Melbourne Melbourne Victoria Australia

5. Murdoch Children’s Research Institute Melbourne Victoria Australia

6. Prince of Wales Hospital Hong Kong China

7. Central Gippsland Health Sale Victoria Australia

8. Department of Paediatrics University of Melbourne Melbourne Victoria Australia

9. Royal Children’s Hospital Melbourne Victoria Australia

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cea.14146

Reference42 articles.

1. Administration of a probiotic with peanut oral immunotherapy: A randomized trial

2. Long-term clinical and immunological effects of probiotic and peanut oral immunotherapy after treatment cessation: 4-year follow-up of a randomised, double-blind, placebo-controlled trial

3. Clinical efficacy and immune regulation with peanut oral immunotherapy

4. Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3)

5. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening of probiotic Lactobacillus to reduce peanut allergy and with potential anti‐allergic activity;Journal of the Science of Food and Agriculture;2023-11-15

2. Advances in the Study of Probiotics for Immunomodulation and Intervention in Food Allergy;Molecules;2023-01-27

3. Oral immunotherapy using boiled peanuts for treating peanut allergy: An open‐label, single‐arm trial;Clinical & Experimental Allergy;2023-01-11

4. Novel perspective on the regulation of food allergy by probiotic: The potential of its structural components;Critical Reviews in Food Science and Nutrition;2022-08-01

5. Biomarkers of airway inflammation and immunotherapy;Clinical & Experimental Allergy;2022-05-30